GreenLight Biosciences Holdings, PBC Warrant
GRNAW
GRNAW was delisted on the 21st of July, 2023.
17 hedge funds and large institutions have $3.65M invested in GreenLight Biosciences Holdings, PBC Warrant in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$964K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$521K |
| 3 |
TAM
Telemark Asset Management
Boston,
Massachusetts
|
+$313K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$312K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$261K |
Top Sellers
GRNAW Hedge Fund Activity: Q1 2021 in Review
17 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q1 2021, worth a combined $3.65M.
Buyers outnumbered sellers: 17 funds opened new GRNAW positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $964K.
- 17 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $3.65M of GreenLight Biosciences Holdings, PBC Warrant stock for Q1 2021.
- 17 funds opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q1 2021 and 0 closed out, a net change of +17 holders.
- The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q1 2021 was Adage Capital Partners, an estimated $964K added.
Based on aggregated 13F filings for Q1 2021.